STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

September 6, 2024

Period of Report

September 5, 2024

Accession Number

0001062993-24-016277